We have previously shown that in obese patients with metabolic-associated fatty liver disease (MAFLD) and type 2 diabetes (T2D), hepatic levels of ACE2 and the cellular TMPRSS2 transcripts were positively correlated with the NAS score of these patients15,16. The gene discussed is ACE2; the disease is type 2 diabetes mellitus.